{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:10:01Z","timestamp":1794442201989,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070912"],"award-info":[{"award-number":["82070912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370899"],"award-info":[{"award-number":["82370899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773326"],"award-info":[{"award-number":["81773326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2019676"],"award-info":[{"award-number":["BE2019676"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Psoriasis is a chronic inflammatory skin disorder characterized by hyperproliferation of keratinocytes and persistent inflammation. Although persistent activation of signal transducer and activator of transcription 3 (STAT3) is implicated in its pathogenesis, the mechanisms underlying the sustained STAT3 activation remain poorly understood. Here, we identify sphingosine-1-phosphate receptor 3 (S1PR3) as a critical regulator of STAT3 activation and psoriasis pathogenesis, orchestrating a self-amplifying circuit that sustains keratinocyte hyperproliferation and chronic inflammation. S1PR3 expression is markedly elevated in psoriatic lesions and correlates with disease severity. Using genetic and pharmacological approaches, we reveal a novel S1PR3\u2013Src\u2013STAT3 signaling axis that drives both early and prolonged STAT3 activation in keratinocytes. Mechanistically, S1PR3 operates through G\u03b1i\/PKA-mediated Src activation, enhancing STAT3 phosphorylation and subsequent transcriptional activity. Importantly, we reveal a previously unrecognized positive feedback loop wherein activated STAT3 directly upregulates S1PR3 expression, perpetuating inflammation and hyperproliferation. Genetic deletion of <jats:italic>S1pr3<\/jats:italic> in mice or pharmacological inhibition of S1PR3 significantly attenuates psoriasis-like skin inflammation, decreasing epidermal hyperplasia, dermal angiogenesis, and inflammatory mediator production. These findings provide new insights into the molecular mechanisms underlying psoriasis and identify S1PR3 as a promising therapeutic target. Our study suggests that disrupting the S1PR3\u2013STAT3 feedback loop may offer a novel strategy for treating psoriasis and potentially other chronic inflammatory diseases driven by persistent STAT3 activation.<\/jats:p>","DOI":"10.1038\/s41419-025-07358-w","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:22:02Z","timestamp":1737397322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Panpan","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9299-4716","authenticated-orcid":false,"given":"Junaid","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaode","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-3482","authenticated-orcid":false,"given":"Wangsen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-008X","authenticated-orcid":false,"given":"Zhiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-5112","authenticated-orcid":false,"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"7358_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496\u2013509.","journal-title":"N Engl J Med."},{"key":"7358_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866\u201373.","journal-title":"Nature."},{"key":"7358_CR3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14:736\u201346.","journal-title":"Nat Rev Cancer."},{"key":"7358_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/jid.2015.82","volume":"135","author":"S Xie","year":"2015","unstructured":"Xie S, Su Z, Zhang B, Ge J, Song S, Sun G, et al. SIRT1 activation ameliorates aldara-induced psoriasiform phenotype and histology in mice. J Investig Dermatol. 2015;135:1915\u20138.","journal-title":"J Investig Dermatol."},{"key":"7358_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005;11:43\u20139.","journal-title":"Nat Med."},{"key":"7358_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","volume":"76","author":"HC Tsai","year":"2016","unstructured":"Tsai HC, Han MH. Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation. Drugs. 2016;76:1067\u201379.","journal-title":"Drugs."},{"key":"7358_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00403-016-1709-9","volume":"309","author":"H Mysliwiec","year":"2017","unstructured":"Mysliwiec H, Baran A, Harasim-Symbor E, Choromanska B, Mysliwiec P, Milewska AJ, et al. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Arch Dermatol Res. 2017;309:79\u201386.","journal-title":"Arch Dermatol Res."},{"key":"7358_CR8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1248\/bpb.27.1392","volume":"27","author":"T Kohno","year":"2004","unstructured":"Kohno T, Tsuji T, Hirayama K, Watabe K, Matsumoto A, Kohno T, et al. A novel immunomodulator, FTY720, prevents spontaneous dermatitis in NC\/Nga mice. Biol Pharm Bull. 2004;27:1392\u20136.","journal-title":"Biol Pharm Bull."},{"key":"7358_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/BOR.0000000000000110","volume":"26","author":"FV Castelino","year":"2014","unstructured":"Castelino FV, Varga J. Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy. Curr Opin Rheumatol. 2014;26:607\u201314.","journal-title":"Curr Opin Rheumatol."},{"key":"7358_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s41422-021-00566-x","volume":"31","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Jia G, Wu C, Wang W, Cheng L, Li Q, et al. Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition. Cell Res. 2021;31:1263\u201374.","journal-title":"Cell Res."},{"key":"7358_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1090202","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang C, He Q, Chen G, Yu J, Cang J, et al. Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages via TWIK2-mediated potassium efflux. Front Immunol. 2023;14:1090202.","journal-title":"Front Immunol."},{"key":"7358_CR12","doi-asserted-by":"crossref","unstructured":"Saurabh K, Mbadhi MN, Prifti KK, Martin KT, Frolova AI. Sphingosine 1-phosphate activates S1PR3 to induce a proinflammatory phenotype in human myometrial cells. Endocrinology. 2023;164:1\u201313.","DOI":"10.1210\/endocr\/bqad066"},{"key":"7358_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41420-022-00943-4","volume":"8","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lian P, Peng Z, Wazir J, Ma C, Wei L, et al. Alpha-7 nicotinic acetylcholine receptor agonist alleviates psoriasis-like inflammation through inhibition of the STAT3 and NF-kappaB signaling pathway. Cell Death Discov. 2022;8:141.","journal-title":"Cell Death Discov."},{"key":"7358_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265517","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, Na M, Yao X, Li C, Li L, Yang G, et al. Integrative single-cell transcriptomic investigation unveils long non-coding RNAs associated with localized cellular inflammation in psoriasis. Front Immunol. 2023;14:1265517.","journal-title":"Front Immunol."},{"key":"7358_CR15","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/jid.2014.28","volume":"134","author":"B Li","year":"2014","unstructured":"Li B, Tsoi LC, Swindell WR, Gudjonsson JE, Tejasvi T, Johnston A, et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Investig Dermatol. 2014;134:1828\u201338.","journal-title":"J Investig Dermatol."},{"key":"7358_CR16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.jid.2020.12.031","volume":"141","author":"L Tang","year":"2021","unstructured":"Tang L, Wang M, Shen C, Wen L, Li M, Wang D, et al. Assay for transposase-accessible chromatin using sequencing analysis reveals a widespread increase in chromatin accessibility in psoriasis. J Investig Dermatol. 2021;141:1745\u201353.","journal-title":"J Investig Dermatol."},{"key":"7358_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362:387\u2013401.","journal-title":"N Engl J Med."},{"key":"7358_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1983.tb11642.x","volume":"109","author":"IM Braverman","year":"1983","unstructured":"Braverman IM. The role of blood vessels and lymphatics in cutaneous inflammatory processes: an overview. Br J Dermatol. 1983;109:89\u201398.","journal-title":"Br J Dermatol."},{"key":"7358_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2133.1995.tb02696.x","volume":"133","author":"IM Leigh","year":"1995","unstructured":"Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol. 1995;133:501\u201311.","journal-title":"Br J Dermatol."},{"key":"7358_CR20","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174:3695\u2013702.","journal-title":"J Immunol."},{"key":"7358_CR21","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","volume":"178","author":"SM Sa","year":"2007","unstructured":"Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol. 2007;178:2229\u201340.","journal-title":"J Immunol."},{"key":"7358_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10753-017-0719-x","volume":"41","author":"B Zhu","year":"2018","unstructured":"Zhu B, Luo GH, Feng YH, Yu MM, Zhang J, Wei J, et al. Apolipoprotein M protects against lipopolysaccharide-induced acute lung injury via sphingosine-1-phosphate signaling. Inflammation. 2018;41:643\u201353.","journal-title":"Inflammation."},{"key":"7358_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217158","volume":"600","author":"YQ Wang","year":"2024","unstructured":"Wang YQ, Ren Y, Gale RP, Niu LT, Huang XJ. Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells. Cancer Lett. 2024;600:217158.","journal-title":"Cancer Lett."},{"key":"7358_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41422-021-00567-w","volume":"32","author":"C Zhao","year":"2022","unstructured":"Zhao C, Cheng L, Wang W, Wang H, Luo Y, Feng Y, et al. Structural insights into sphingosine-1-phosphate recognition and ligand selectivity of S1PR3-Gi signaling complexes. Cell Res. 2022;32:218\u201321.","journal-title":"Cell Res."},{"key":"7358_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1124\/pr.110.003111","volume":"62","author":"J Chun","year":"2010","unstructured":"Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev. 2010;62:579\u201387.","journal-title":"Pharmacol Rev."},{"key":"7358_CR26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00018-016-2405-9","volume":"74","author":"D Kamato","year":"2017","unstructured":"Kamato D, Mitra P, Davis F, Osman N, Chaplin R, Cabot PJ, et al. Ga(q) proteins: molecular pharmacology and therapeutic potential. Cell Mol Life Sci. 2017;74:1379\u201390.","journal-title":"Cell Mol Life Sci."},{"key":"7358_CR27","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1074\/jbc.274.8.4626","volume":"274","author":"JR Van Brocklyn","year":"1999","unstructured":"Van Brocklyn JR, Tu Z, Edsall LC, Schmidt RR, Spiegel S. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem. 1999;274:4626\u201332.","journal-title":"J Biol Chem."},{"key":"7358_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0092-8674(83)90392-6","volume":"34","author":"FR Cross","year":"1983","unstructured":"Cross FR, Hanafusa H. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation. Cell. 1983;34:597\u2013607.","journal-title":"Cell."},{"key":"7358_CR29","first-page":"121","volume":"1287","author":"MT Brown","year":"1996","unstructured":"Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta. 1996;1287:121\u201349.","journal-title":"Biochim Biophys Acta."},{"key":"7358_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2413","volume":"4","author":"GN Armaiz-Pena","year":"2013","unstructured":"Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, et al. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis. Nat Commun. 2013;4:1403.","journal-title":"Nat Commun."},{"key":"7358_CR31","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.1074\/jbc.RA120.015400","volume":"295","author":"N Pakharukova","year":"2020","unstructured":"Pakharukova N, Masoudi A, Pani B, Staus DP, Lefkowitz RJ. Allosteric activation of proto-oncogene kinase Src by GPCR-beta-arrestin complexes. J Biol Chem. 2020;295:16773\u201384.","journal-title":"J Biol Chem."},{"key":"7358_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cellsig.2004.07.011","volume":"17","author":"CM Waters","year":"2005","unstructured":"Waters CM, Connell MC, Pyne S, Pyne NJ. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell Signal. 2005;17:263\u201377.","journal-title":"Cell Signal."},{"key":"7358_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.tcb.2017.05.008","volume":"27","author":"R Ranjan","year":"2017","unstructured":"Ranjan R, Dwivedi H, Baidya M, Kumar M, Shukla AK. Novel structural insights into GPCR-beta-arrestin interaction and signaling. Trends Cell Biol. 2017;27:851\u201362.","journal-title":"Trends Cell Biol."},{"key":"7358_CR34","doi-asserted-by":"crossref","unstructured":"Cassier E, Gallay N, Bourquard T, Claeysen S, Bockaert J, Crepieux P, et al. Phosphorylation of beta-arrestin2 at Thr(383) by MEK underlies beta-arrestin-dependent activation of Erk1\/2 by GPCRs. Elife. 2017;6:e23777.","DOI":"10.7554\/eLife.23777"},{"key":"7358_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","volume":"122","author":"JM Beaulieu","year":"2005","unstructured":"Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 2005;122:261\u201373.","journal-title":"Cell."},{"key":"7358_CR36","doi-asserted-by":"publisher","first-page":"e92926","DOI":"10.1371\/journal.pone.0092926","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang S, Gong H, Jiang G, Ye Y, Wu J, You J, et al. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent beta-arrestin2 pathways. PLoS ONE. 2014;9:e92926.","journal-title":"PLoS ONE."},{"key":"7358_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0308-6","volume":"12","author":"R Cipriani","year":"2015","unstructured":"Cipriani R, Chara JC, Rodriguez-Antiguedad A, Matute C. FTY720 attenuates excitotoxicity and neuroinflammation. J Neuroinflamm 2015;12:86.","journal-title":"J Neuroinflamm"},{"key":"7358_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1212\/WNL.0b013e3181ebdd64","volume":"75","author":"M Mehling","year":"2010","unstructured":"Mehling M, Lindberg R, Raulf F, Kuhle J, Hess C, Kappos L, et al. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology. 2010;75:403\u201310.","journal-title":"Neurology."},{"key":"7358_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108665","volume":"107","author":"F Zehra Okus","year":"2022","unstructured":"Zehra Okus F, Busra Azizoglu Z, Canatan H, Eken A. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo. Int Immunopharmacol. 2022;107:108665.","journal-title":"Int Immunopharmacol."},{"key":"7358_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11910-011-0216-9","volume":"11","author":"M Mehling","year":"2011","unstructured":"Mehling M, Kappos L, Derfuss T. Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions. Curr Neurol Neurosci Rep 2011;11:492\u20137.","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07358-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07358-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07358-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:22:05Z","timestamp":1737397325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07358-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7358"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07358-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. The animal experiment was approved by the Medical School of Nanjing University Ethics Committee. Human skin biopsy specimens were obtained with informed consent and were approved by the First Affiliated Hospital of Nanjing Medical University Clinical Research Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to participate"}}],"article-number":"31"}}